| 2024-11-23 |
[Articles] Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial |
Sophie Leboulleux, Claire Bournaud, Cecile N Chougnet, Livia Lamartina, Slimane Zerdoud, Christine Do Cao, Bogdan Catargi, Inna Dygai, Antony Kelly, Marie-Luce Barge, Pierre Vera, Daniela Rusu, Olivier Schneegans, Julie Roux, Perrine Raymond, Danielle Ben |
|
| 2024-11-23 |
[Comment] One step closer to the end of postoperative radioactive iodine thyroid remnant ablation |
Frederik A Verburg, Bart de Keizer |
|
| 2024-11-16 |
[Articles] Overweight and obesity among Israeli adolescents and the risk for serious morbidity in early young adulthood: a nationwide retrospective cohort study |
Yair Zloof, Maya Nitecki, Maya Simchoni, Ofek Adar, Avishai M Tsur, Estela Derazne, Dorit Tzur, Jacob Rotschield, Maya Braun, Orit Pinhas-Hamiel, Naomi Fliss Isakov, Hadar Milloh-Raz, Dan Nemet, Dror Dicker, Avi Moyal, Oded Scheuerman, Zivan Beer, Marius |
|
| 2024-11-16 |
[Comment] Associations of obesity with co-morbidities in early adult life |
Thorkild I A Sørensen |
|
| 2024-11-14 |
[Articles] Setmelanotide in patients aged 2–5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial |
Jesús Argente, Charles F Verge, Uzoma Okorie, Ilene Fennoy, Megan M Kelsey, Casey Cokkinias, Cecilia Scimia, Hak-Myung Lee, I Sadaf Farooqi |
|
| 2024-11-14 |
[Comment] Setmelanotide for the treatment of severe early-childhood genetic obesity |
Christian L Roth |
|
| 2024-11-14 |
[Editorial] Putting wellbeing at the core of diabetes care |
The Lancet Diabetes & Endocrinology |
|
| 2024-11-13 |
[Review] Hypothalamic obesity: from basic mechanisms to clinical perspectives |
Jesús Argente, I Sadaf Farooqi, Julie A Chowen, Peter Kühnen, Miguel López, Eugenia Morselli, Hoong-Wei Gan, Helen A Spoudeas, Martin Wabitsch, Manuel Tena-Sempere |
|
| 2024-11-12 |
[Articles] Trends in the incidence of young-adult-onset diabetes by diabetes type: a multi-national population-based study from an international diabetes consortium |
Dianna J Magliano, Lei Chen, Jedidiah I Morton, Agus Salim, Bendix Carstensen, Edward W Gregg, Meda E Pavkov, Martti Arffman, Helen M Colhoun, Kyoung Hwa Ha, Tomoaki Imamura, György Jermendy, Dae Jung Kim, Zoltán Kiss, Didac Mauricio, Stuart J McGurnaghan |
|
| 2024-11-12 |
[Comment] Global diabetes incidence trends in young adults |
Lars C Stene |
|
| 2024-11-09 |
[Comment] Disease modifying therapies in diabetes and endocrinology |
Chantal Mathieu |
|
| 2024-11-08 |
[Comment] Staging schema for early diagnosis of prediabetes |
Michael Bergman, Muhammad Abdul-Ghani, Juliana Chan, Maria Inês Schmidt, Joon Ha, Sang Soo Kim, Arthur S Sherman, Ram Jagannathan, Jaakko Tuomilehto |
|
| 2024-10-25 |
[Articles] Depression symptoms, wellbeing, health-related quality of life, and diabetes-related distress in novel subtypes of recent-onset diabetes in Germany: a 5-year observational follow-up study |
Jana Sommer, Sandra Olivia Borgmann, Veronika Gontscharuk, Oana Patricia Zaharia, Haifa Maalmi, Christian Herder, Robert Wagner, Klaus Strassburger, Martin Schön, Volker Burkart, Julia Szendroedi, Andreas F H Pfeiffer, Stefan Bornstein, Matthias Blüher, J |
|
| 2024-10-25 |
[Comment] Diabetes subtypes and patient-reported outcomes |
Frank J Snoek |
|
| 2024-10-24 |
[Articles] Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92) |
Beryl Lin, Ruth L Coleman, Fiona Bragg, Ernesto Maddaloni, Rury R Holman, Amanda I Adler |
|
| 2024-10-24 |
[Comment] Young adult-onset type 2 diabetes heralds a poor prognosis |
Soon H Song, Brian M Frier |
|
| 2024-10-17 |
[Articles] Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study |
Luis Masana, Alberto Zambon, Claus Peter Schmitt, Christina Taylan, Joenna Driemeyer, Hofit Cohen, Paola Sabrina Buonuomo, Abdullah Alashwal, Mohammed Al-Dubayee, Naji Kholaif, José Luis Diaz-Diaz, Faouzi Maatouk, Sergio Martinez-Hervas, Brian Mangal, San |
|
| 2024-10-17 |
[Comment] Lomitapide for the treatment of homozygous familial hypercholesterolaemia in children |
Liam R Brunham, Robert A Hegele |
|
| 2024-10-16 |
[Correspondence] Declaration of Lisbon |
Catarina Limbert, Jamie Wood, Sabine Hofer, Jannet Svensson, Fergus Cameron, Roque Cardona-Hernandez, Sylvia Lion, David M Maahs |
|
| 2024-10-15 |
[Viewpoint] Continuous glucose sensor accuracy: beyond the headline metric |
Nick Oliver, Monika Reddy, Lala Leelarathna |
|
| 2024-10-15 |
[Viewpoint] Is it time to revisit the recommendations for initiation of menopausal hormone therapy? |
Sasha Taylor, Susan R Davis |
|
| 2024-10-12 |
[Comment] Lessons to learn from the 2024 NICE guideline on adrenal insufficiency |
Jiawen Dong, Jeremy W Tomlinson |
|
| 2024-10-11 |
[Editorial] Stem-cell therapy for diabetes: the hope continues |
The Lancet Diabetes & Endocrinology |
|
| 2024-10-08 |
[Articles] Evolving epidemiological patterns of thyroid cancer and estimates of overdiagnosis in 2013–17 in 63 countries worldwide: a population-based study |
Mengmeng Li, Luigino Dal Maso, Margherita Pizzato, Salvatore Vaccarella |
|
| 2024-10-08 |
[Comment] The growing global burden of thyroid cancer overdiagnosis |
Cari M Kitahara |
|
| 2024-10-05 |
[Articles] Continuous glucose monitoring-based metrics and the duration of hypoglycaemia events with once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-naive type 2 diabetes: an exploratory analysis of ONWARDS 1 |
Richard M Bergenstal, Björg Ásbjörnsdóttir, Sara K Watt, Ildiko Lingvay, Julia K Mader, Tomoyuki Nishida, Julio Rosenstock |
|
| 2024-10-05 |
[Comment] Ultra-long-acting insulin: a new chapter in diabetes therapy? |
Muhammad Ali Karamat, Srikanth Bellary, Anthony H Barnett |
|
| 2024-10-05 |
[Articles] Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study |
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC) |
|
| 2024-10-05 |
[Comment] Type 2 diabetes in familial hypercholesterolaemia: another look at traditional risk factors |
Marina Cuchel, Archna Bajaj |
|
| 2024-09-24 |
[Review] Aberrant hormone receptors regulate a wide spectrum of endocrine tumors |
André Lacroix, Isabelle Bourdeau, Fanny Chasseloup, Peter Kamenický, Antoine-Guy Lopez, Estelle Louiset, Hervé Lefebvre |
|
| 2024-09-24 |
[Articles] Dysglycaemia screening and its prognostic impact in patients with coronary artery disease: experiences from the EUROASPIRE IV and V cohort studies |
Giulia Ferrannini, Jaakko Tuomilehto, Guy De Backer, Kornelia Kotseva, Linda Mellbin, Oliver Schnell, David Wood, Dirk De Bacquer, Lars Rydén |
|
| 2024-09-24 |
[Review] Osteopenia: a key target for fracture prevention |
Ian R Reid, Michael R McClung |
|
| 2024-09-24 |
[Comment] Dysglycaemia in cardiovascular disease: what's the best glycaemic risk predictor? |
Stefano Del Prato |
|
| 2024-09-14 |
[Corrections] Correction to Lancet Diabetes Endocrinol 2024; 12: 39–50 |
|
|
| 2024-09-13 |
[Editorial] The unhealthy politics of health |
The Lancet Diabetes & Endocrinology |
|
| 2024-09-10 |
[Comment] Muscle matters: the effects of medically induced weight loss on skeletal muscle |
Carla M Prado, Stuart M Phillips, M Cristina Gonzalez, Steven B Heymsfield |
|
| 2024-09-07 |
[Articles] Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial |
Mikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, Jeffrey S Berger, Harmony R Reynolds, Stavroula Boumakis, Andrew D Althouse, Scott D Solomon, Ankeet S Bhatt, Alexander Peikert, James F Luther, Eric S Leifer, Andrei L Kindzelski, Mary Cushman, Michell |
|
| 2024-09-07 |
[Articles] Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials |
Claire Vale, Peter J Godolphin, David Fisher, Peter W Horby, Mikhail N Kosiborod, Judith S Hochman, Katie Webster, Julian P T Higgins, Andrew D Althouse, Otavio Berwanger, Remo H M Furtado, Samvel B Gasparyan, Richard Haynes, Gary G Koch, Martin Landray, |
|
| 2024-09-07 |
[Comment] Sodium–glucose co-transporter type-2 inhibitors for hospitalised patients with COVID-19: safe but not protective |
André J Scheen |
|
| 2024-09-07 |
[Articles] Islet-after-kidney transplantation versus kidney alone in kidney transplant recipients with type 1 diabetes (KAIAK): a population-based target trial emulation in France |
Mehdi Maanaoui, Rémi Lenain, Yohann Foucher, Fanny Buron, Gilles Blancho, Corinne Antoine, Sophie Caillard, Laurence Kessler, Moglie Le Quintrec, Orianne Villard, Dany Anglicheau, Matthias Büchler, Albane Brodin-Sartorius, Luc Frimat, Paolo Malvezzi, Sand |
|
| 2024-09-07 |
[Comment] Islet transplantation in kidney transplant recipients with type 1 diabetes |
Shareen Forbes, Thomas W H Kay |
|
| 2024-09-05 |
[Comment] International Day of Charity: what does charity mean for diabetes? |
David Beran, Stéphane Besançon |
|
| 2024-09-04 |
[In Focus] Reducing sodium intake: step-by-step targets yield success |
Talha Burki |
|
| 2024-09-04 |
[Corrections] Correction to Lancet Diabetes Endocrinol 2024; 12: 602–03 |
|
|
| 2024-08-30 |
[Articles] Adiposity and metabolic health in Asian populations: an epidemiological study using dual-energy x-ray absorptiometry in Singapore |
Theresia Mina, Wubin Xie, Dorrain Yanwen Low, Xiaoyan Wang, Benjamin Chih Chiang Lam, Nilanjana Sadhu, Hong Kiat Ng, Nur-Azizah Aziz, Terry Yoke Yin Tong, Swat Kim Kerk, Wee Lin Choo, Guo Liang Low, Halimah Ibrahim, Liming Lim, E Shyong Tai, Gervais Wansa |
|
| 2024-08-30 |
[Comment] Why does visceral adiposity not explain higher type 2 diabetes prevalence in Asian Indians? |
Viswanathan Mohan, Ranjit Mohan Anjana |
|
| 2024-08-27 |
[Comment] Transitioning to stage 3 type 1 diabetes: when to start insulin |
Rachel E J Besser, Kurt J Griffin |
|
| 2024-08-22 |
[Correspondence] Sociodemographic and health-related differences in non-diabetic hyperglycaemia and undiagnosed type 2 diabetes in England during 2013–19: a cross-sectional study |
Emma Campbell, Ellie Macey, Caitlin Kneebone-Hopkins, Chris Shine, Vahé Nafilyan, Nicholas Brown, Martin White, Ross Jones, Kamlesh Khunti, Katie Finning |
|
| 2024-08-21 |
[Correspondence] Association of age with gaps in diabetes-related care and hospitalisations from childhood to young adulthood in Quebec, Canada: a cohort study |
Meranda Nakhla, Elham Rahme, Marc Simard, Véronique Boiteau, Kaberi Dasgupta |
|
| 2024-08-21 |
[Comment] Paediatric thyroid lesions: lessons from recent guidelines |
Esther Diana Rossi, Huiying Wang, Vivian Lee Weiss |
|
| 2024-08-21 |
[Comment] Closed-loop systems: a bridge to cell therapy for type 1 diabetes? |
Sufyan Hussain, Katarina Braune, Shareen Forbes, Peter A Senior |
|
| 2024-08-17 |
[Comment] Increased prevalence of younger onset type 2 diabetes: why and what could be done? |
Naveed Sattar, Brian Kennon, Anna D White |
|
| 2024-08-17 |
[Review] Male hypogonadism: pathogenesis, diagnosis, and management |
Nipun Lakshitha De Silva, Nikoleta Papanikolaou, Mathis Grossmann, Leen Antonio, Richard Quinton, Bradley David Anawalt, Channa N Jayasena |
|
| 2024-08-09 |
[Editorial] Diabetes-related complications: a toll too high |
The Lancet Diabetes & Endocrinology |
|
| 2024-08-07 |
[Comment] Implementing type 2 diabetes remission interventions in the real world: what have we learnt? |
Srikanth Bellary |
|
| 2024-08-06 |
[Articles] Early findings from the NHS Type 2 Diabetes Path to Remission Programme: a prospective evaluation of real-world implementation |
Jonathan Valabhji, Tessa Gorton, Emma Barron, Soraya Safazadeh, Fiona Earnshaw, Clare Helm, Martin Virr, John Kernan, Shaun Crowe, Paul Aveyard, John Wilding, Tony Willis, Louisa Ells, Simon O'Neill, Elizabeth Robertson, Susan Jebb, Roy Taylor, Chirag Bak |
|
| 2024-08-02 |
[Personal View] Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes |
Muhammad Abdul-Ghani, Pietro Maffei, Ralph Anthony DeFronzo |
|
| 2024-08-02 |
[Comment] Sex differences in familial hypercholesterolaemia |
Xavier Rossello, Francisca Caimari |
|
| 2024-08-02 |
[Corrections] Correction to Lancet Diabetes Endocrinol 2024; published online July 19. https://doi.org/10.1016/S2213-8587(24)00157-8 |
|
|
| 2024-08-02 |
[Articles] Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study |
Leopoldo Pérez de Isla, Antonio J Vallejo-Vaz, Gerald F Watts, Ovidio Muñiz-Grijalvo, Rodrigo Alonso, Jose L Diaz-Diaz, Raquel Arroyo-Olivares, Rocio Aguado, Rosa Argueso, Marta Mauri, Manuel J Romero, Pilar Álvarez-Baños, Dolores Mañas, José María Cepeda |
|
| 2024-08-02 |
[In Focus] Iodine deficiency in Europe: vigilance and action required |
Talha Burki |
|
| 2024-07-30 |
[Articles] Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial |
Barbara M McGowan, Jens M Bruun, Matt Capehorn, Sue D Pedersen, Kirsi H Pietiläinen, Hanna Angelene Kudiyanur Muniraju, Maria Quiroga, Anette Varbo, David C W Lau, STEP 10 Study Group |
|
| 2024-07-30 |
[Comment] Prediabetes remission in people with obesity |
Michael Bergman |
|
| 2024-07-26 |
[Correspondence] Embracing community sport to promote global health |
Nikolaj Gilbert, Oliver Dudfield, Fiona Bull |
|
| 2024-07-25 |
[Corrections] Correction to Lancet Diabetes Endocrinol 2024; published online July 22. https://doi.org/10.1016/S2213-8587(24)00163-3 |
|
|
| 2024-07-23 |
[Review] Bone health in adults with obesity before and after interventions to promote weight loss |
Julien Paccou, Juliet E Compston |
|
| 2024-07-20 |
[Review] Understanding the cause of type 2 diabetes |
Roy Taylor |
|
| 2024-07-16 |
[Correspondence] The evidence for achondroplasia in 1st century AD Italy |
Francesco M Galassi, Laura Landini, Kristina Killgrove, Marco Artico, Lorenzo Rossi, Veronica Papa, Elena Varotto |
|
| 2024-07-12 |
[Editorial] Precision nutrition: a step too far? |
The Lancet Diabetes & Endocrinology |
|
| 2024-07-10 |
[In Focus] The deep pockets of health-harming industries |
Talha Burki |
|
| 2024-07-09 |
[Comment] SGLT2 inhibitors and GLP-1 receptor agonists: the definitive combination? |
Carlos Escobar Cervantes |
|
| 2024-07-09 |
[Articles] Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials |
Ellen M Apperloo, Brendon L Neuen, Robert A Fletcher, Niels Jongs, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, William G Herrington, Silvio E Inzucchi, Meg J Jardine, Chih-Chin Liu, Kenneth W Mahaffey, Darren K McGuire, John J V McMur |
|
| 2024-07-03 |
[Correspondence] Impact of higher BMI on cardiometabolic risk: does height matter? |
Norbert Stefan, Catarina Schiborn, Jürgen Machann, Andreas L Birkenfeld, Matthias B Schulze |
|
| 2024-07-02 |
[Articles] Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial |
Allison Ross Eckard, Qian Wu, Abdus Sattar, Kianoush Ansari-Gilani, Danielle Labbato, Theresa Foster, Aaron A Fletcher, Ruth O Adekunle, Grace A McComsey |
|
| 2024-07-02 |
[Comment] Semaglutide in people with HIV-associated lipohypertrophy |
Y Joseph Hwang, Todd T Brown, Jacqueline Capeau |
|
| 2024-06-26 |
[Viewpoint] The potential role for artificial intelligence in fracture risk prediction |
Namki Hong, Danielle E Whittier, Claus-C Glüer, William D Leslie |
|
| 2024-06-24 |
[Articles] Early pregnancy HbA1c as the first screening test for gestational diabetes: results from three prospective cohorts |
Ponnusamy Saravanan, Mohan Deepa, Zain Ahmed, Uma Ram, Tarakeswari Surapaneni, Sailaja Devi Kallur, Papa Desari, Seshadri Suresh, Ranjit Mohan Anjana, Wesley Hannah, Chockalingam Shivashri, Saite Hemavathy, Nithya Sukumar, Wycliffe K Kosgei, Astrid Christ |
|
| 2024-06-24 |
[Comment] Value of early pregnancy HbA1c to predict gestational diabetes |
Yashdeep Gupta, David Simmons |
|
| 2024-06-18 |
[Comment] Call for effective therapies for preventing dementia in people with type 2 diabetes |
Thomas T van Sloten, José A Luchsinger, Lenore J Launer, Mark Strachan, Tali Cukierman-Yaffe, Hertzel C Gerstein, Naveed Sattar, Geert Jan Biessels |
|
| 2024-06-07 |
[Editorial] Alarming rise in young-onset type 2 diabetes |
The Lancet Diabetes & Endocrinology |
|
| 2024-06-04 |
[Articles] Associations between BMI and hospital resource use in patients hospitalised for COVID-19 in England: a community-based cohort study |
James Altunkaya, Carmen Piernas, Koen B Pouwels, Susan A Jebb, Philip Clarke, Nerys M Astbury, Jose Leal |
|
| 2024-06-04 |
[Comment] Association between BMI and COVID-19 on hospital budgets |
Maya Nitecki, Arnon Afek, Gilad Twig |
|
| 2024-05-31 |
[Review] Causes, prevention, and management of diabetes-related foot ulcers |
William Jeffcoate, Edward J Boyko, Fran Game, Prue Cowled, Eric Senneville, Robert Fitridge |
|
| 2024-05-31 |
[Comment] Diabetes distress: the psychological burden of living with diabetes |
Lydia Poole, Ruth A Hackett |
|
| 2024-05-31 |
[Correspondence] Lack of access to insulin: undermining the Rights of the Child |
Olivia Heller, Olivier Duperrex, Philip D Jaffé, Jeffrey Goldhagen, Carol A Abidha, Ann Skelton, Mikiko Otani, Yvon Heller, Jean-Dominique Vassalli, David Beran |
|
| 2024-05-28 |
[Personal View] Advancing diabetes surveillance ecosystems: a case study of India |
Jithin Sam Varghese, Emily N Peterson, Mohammed K Ali, Nikhil Tandon |
|
| 2024-05-24 |
[Personal View] Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scores |
Mugdha V Joglekar, Simranjeet Kaur, Flemming Pociot, Anandwardhan A Hardikar |
|
| 2024-05-23 |
[Comment] Measuring serum testosterone in women |
David J Handelsman, Susan R Davis |
|
| 2024-05-21 |
[In Focus] The ongoing quest for worldwide iodine sufficiency |
Ray Cavanaugh |
|
| 2024-05-18 |
[Articles] Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis |
Muhammad Shariq Usman, Deepak L Bhatt, Ishaque Hameed, Stefan D Anker, Alice Y Y Cheng, Adrian F Hernandez, William Schuyler Jones, Muhammad Shahzeb Khan, Mark C Petrie, Jacob A Udell, Tim Friede, Javed Butler |
|
| 2024-05-18 |
[Comment] SGLT2 inhibitors in clinical practice |
Lars Rydén, Anna Norhammar |
|
| 2024-05-11 |
[Editorial] Sleep: a neglected public health issue |
The Lancet Diabetes & Endocrinology |
|
| 2024-05-07 |
[Review] Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review |
Moath S Alsaqaaby, Sarah Cooney, Carel W le Roux, Dimitri J Pournaras |
|
| 2024-05-07 |
[Correspondence] Effect of population-wide screening for presymptomatic early-stage type 1 diabetes on paediatric clinical care |
Ezio Bonifacio, Christiane Winkler, Peter Achenbach, Anette-Gabriele Ziegler |
|
| 2024-05-07 |
[Corrections] Correction to Lancet Diabetes Endocrinol 2024; 12: 233–46 |
|
|
| 2024-05-07 |
[Corrections] Correction to Lancet Diabetes Endocrinol 2024; 12: 301–02 |
|
|
| 2024-05-04 |
[Articles] Use of melatonin supplements and risk of type 2 diabetes and cardiovascular diseases in the USA: insights from three prospective cohort studies |
Yanping Li, Tianyi Huang, Susan Redline, Walter C Willett, JoAnn E Manson, Eva S Schernhammer, Frank B Hu |
|
| 2024-05-04 |
[Comment] Melatonin: is it really a cardiovascular wonder pill for shift workers? |
Pei Xue, Diana A Nôga, Christian Benedict |
|
| 2024-04-30 |
[Articles] Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial |
Christian L Roth, Cecilia Scimia, Ashley H Shoemaker, Michael Gottschalk, Jennifer Miller, Guojun Yuan, Sonali Malhotra, M Jennifer Abuzzahab |
|
| 2024-04-30 |
[Articles] Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial |
Katrien Benhalima, Kaat Beunen, Nancy Van Wilder, Dominique Ballaux, Gerd Vanhaverbeke, Youri Taes, Xavier-Philippe Aers, Frank Nobels, Joke Marlier, Dahae Lee, Joke Cuypers, Vanessa Preumont, Sarah E Siegelaar, Rebecca C Painter, Annouschka Laenen, Piete |
|
